LRRK2 and Parkinson disease: The present study reveals that 10-NO2-OA dose-dependently limits increases in rotenone-induced LRRK2 kinase activity in nigrostriatal dopamine neurons and may represent a central mechanism of action 10-NO2-OA in countering aspects of PD pathogenesis.